Effect of MAO-B Inhibitors on Neurometabolic Profile of Patients Affected by Parkinson Disease: A Proton Magnetic Resonance Spectroscopy Study

Parkinson’s Disease (PD) is the most common neurodegenerative movement disorder whose treatment is symptomatic. No suitable methods for assessing the effects of dopaminergic drugs on disease progression in clinical trials have yet been provided. The aim of this longitudinal study is to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonanno, Lilla, Ciurleo, Rosella, Marino, Silvia, Ruvolo, Claudio, Morabito, Rosa, Bramanti, Alessia, Corallo, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999805/
https://www.ncbi.nlm.nih.gov/pubmed/35407539
http://dx.doi.org/10.3390/jcm11071931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999805/
https://www.ncbi.nlm.nih.gov/pubmed/35407539
http://dx.doi.org/10.3390/jcm11071931

Ejemplares similares